Language
English
Publication Date
1-1-2024
Journal
Gut Microbes
DOI
10.1080/19490976.2024.2385117
PMID
39120056
PMCID
PMC11318715
PubMedCentral® Posted Date
8-9-2024
PubMedCentral® Full Text Version
Post-print
Abstract
Autism spectrum disorders (ASD) are highly heritable, heterogeneous neurodevelopmental disorders characterized by clinical presentation of atypical social, communicative, and repetitive behaviors. Over the past 25 years, hundreds of ASD risk genes have been identified. Many converge on key molecular pathways, from translational control to those regulating synaptic structure and function. Despite these advances, therapeutic approaches remain elusive. Emerging data unearthing the relationship between genetics, microbes, and immunity in ASD suggest an integrative physiology approach could be paramount to delivering therapeutic breakthroughs. Indeed, the advent of large-scale multi-OMIC data acquisition, analysis, and interpretation is yielding an increasingly mechanistic understanding of ASD and underlying risk factors, revealing how genetic susceptibility interacts with microbial genetics, metabolism, epigenetic (re)programming, and immunity to influence neurodevelopment and behavioral outcomes. It is now possible to foresee exciting advancements in the treatment of some forms of ASD that could markedly improve quality of life and productivity for autistic individuals. Here, we highlight recent work revealing how gene X maternal exposome interactions influence risk for ASD, with emphasis on the intrauterine environment and fetal neurodevelopment, host-microbe interactions, and the evolving therapeutic landscape for ASD.
Keywords
Humans, Autism Spectrum Disorder, Female, Pregnancy, Exposome, Gastrointestinal Microbiome, Risk Factors, Genetic Predisposition to Disease, Animals, Autistic Disorder, Host–microbe interactions, gut-microbiota-brain axis, autism spectrum disorder, neurodevelopmental disorders, hologenome, early life, neuroimmune
Published Open-Access
yes
Recommended Citation
Claudia M Di Gesù and Shelly A Buffington, "The Early Life Exposome and Autism Risk: A Role for the Maternal Microbiome?" (2024). Faculty, Staff and Students Publications. 8939.
https://digitalcommons.library.tmc.edu/baylor_docs/8939